14don MSN
CBSE Class 12 biology exam 2026: Faculty insights on important chapters, diagrams and revision
The CBSE Class 12 Biology exam is scheduled for March 27, 2026. Experts advise students to focus on key topics like Genetics, ...
If you are a Class 12 science student, chances are you have come across this question more than once. Should you choose Pharmacy or Biotechnology? Both sound promising. Both fall under life sciences.
CBSE Class 12 Biology Pre Board Sample Paper 2025-2026: The CBSE Class 12 Biology Pre-Board Exam 2026 will be conducted on 27 March 2026 (Friday). As the exam date approaches, students are preparing ...
New datesheet of CBSE class 10, 12: The Central Board of Secondary Education (CBSE) has deferred the Class 10 and Class 12 examinations that were set to begin on March 3, 2026, citing administrative ...
Every year, TechCrunch’s Startup Battlefield pitch contest draws thousands of applicants. We whittle those applications down to the top 200 contenders, and of them, the top 20 compete on the big stage ...
Trinity Biotech plc (NASDAQ: TRIB) stock surged Tuesday after the diagnostics company announced a pair of developments that significantly altered its near- and long-term outlook. Investors reacted ...
Follow the steps below to download the CBSE Time Table 2026 PDF for Classes 10 and 12 from the official CBSE website: Visit the official CBSE website: Go to cbse.gov.in. Click on the “Main Website” ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Thousands of workers lost their ...
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top of ...
- Company also reports a key milestone of Adjusted EBITDA1positive operations in Q3 2025 and expects to achieve strong additional profitability growth in Q1 and Q2 2026 through continued strong ...
SynaptixBio, the only company licensed to commercialise a treatment for a rare, deadly disease, says the Priority Review Voucher scheme is a lifeline for smaller biotechs On December 1st, the US House ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results